StreetInsider.com News Articles

Form SCHEDULE 13D/A Neuronetics, Inc. Filed by: Chernett Jorey

Mon, 24 Aug 2026 20:03:00 -0400

si-local-file:///var/storage/secattach/20260824/26969538.html

Form SCHEDULE 13D/A Neuronetics, Inc. Filed by: Chernett Jorey

Mon, 24 Aug 2026 20:03:00 -0400

si-local-file:///var/storage/secattach/20260824/26969538.html

Form 144 Neuronetics, Inc. Filed by: MACAN WILLIAM ANDREW

Wed, 19 Aug 2026 14:13:00 -0400

si-local-file:///var/storage/secattach/20260819/26949471.html

Form 144 Neuronetics, Inc. Filed by: MACAN WILLIAM ANDREW

Wed, 19 Aug 2026 14:13:00 -0400

si-local-file:///var/storage/secattach/20260819/26949471.html

Form 144 Neuronetics, Inc. Filed by: MACAN WILLIAM ANDREW

Tue, 18 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260818/26945056.html

Form 144 Neuronetics, Inc. Filed by: MACAN WILLIAM ANDREW

Tue, 18 Aug 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260818/26945056.html

Form 8-K Neuronetics, Inc. For: Aug 11

Mon, 17 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260817/26938038.html

Form 8-K Neuronetics, Inc. For: Aug 11

Mon, 17 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260817/26938038.html

Form 4 Neuronetics, Inc. For: Aug 13 Filed by: Chernett Jorey

Mon, 17 Aug 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260817/26936216.html

Form 4 Neuronetics, Inc. For: Aug 13 Filed by: Chernett Jorey

Mon, 17 Aug 2026 10:14:00 -0400

si-local-file:///var/storage/secattach/20260817/26936216.html

Form SCHEDULE 13G Neuronetics, Inc. Filed by: Point72 Asset Management, L.P.

Fri, 14 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26930807.html

Form SCHEDULE 13G Neuronetics, Inc. Filed by: Point72 Asset Management, L.P.

Fri, 14 Aug 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20260814/26930807.html

Form S-8 Neuronetics, Inc.

Tue, 11 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260811/26907202.html

Form S-8 Neuronetics, Inc.

Tue, 11 Aug 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260811/26907202.html

Form 10-Q Neuronetics, Inc. For: Jun 30

Tue, 11 Aug 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260811/26906234.html

Form 10-Q Neuronetics, Inc. For: Jun 30

Tue, 11 Aug 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260811/26906234.html

Neuronetics (STIM) PT Raised to $6 at BTIG

Tue, 11 Aug 2026 13:54:28 -0400

(Updated - August 11, 2026 1:54 PM EDT)

BTIG analyst Sam Eiber raised the price target on Neuronetics (NASDAQ: STIM) to $6.00 (from $5.00) while maintaining a Buy rating.

The analyst commented: "Neuronetics delivered a top-line Q2 beat with total revenue of $41.6M (+9% y/y; consensus $40.2M), but the most notable development was the company's first inflection into positive adjusted EBITDA territory at $0.3M (consensus -$3.7M). Results were driven by another strong quarter from the Greenbrook clinic business (+17% y/y), with continued momentum across both Spravato and TMS and improved reimbursement rates. Revenue cycle management improvements (more disciplined patient eligibility qualification upfront,

Neuronetics (STIM) PT Raised to $6 at BTIG

Tue, 11 Aug 2026 13:54:28 -0400

(Updated - August 11, 2026 1:54 PM EDT)

BTIG analyst Sam Eiber raised the price target on Neuronetics (NASDAQ: STIM) to $6.00 (from $5.00) while maintaining a Buy rating.

Form 8-K Neuronetics, Inc. For: Aug 11

Tue, 11 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260811/26901907.html

Form 8-K Neuronetics, Inc. For: Aug 11

Tue, 11 Aug 2026 08:05:00 -0400

si-local-file:///var/storage/secattach/20260811/26901907.html

Neuronetics (STIM) Tops Q2 EPS by 7c

Tue, 11 Aug 2026 07:59:58 -0400

Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $41.57 million versus the consensus estimate of $40.11 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Tue, 11 Aug 2026 07:50:00 -0400

MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced its financial and operating results for the second quarter of 2026.

Second Quarter 2026 Financial Highlights

Total revenue of $41.6 million, up 9.1% compared to the second quarter of 2025
Greenbrook revenue of $26.9 million, up 16.8% compared to the second quarter of 2025
Adjusted EBITDA of $0.3 million compared to a loss of

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Tue, 11 Aug 2026 07:50:00 -0400

MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced its financial and operating results for the second quarter of 2026.

Second Quarter 2026 Financial Highlights

Total revenue of $41.6 million, up 9.1% compared to the second quarter of 2025
Greenbrook revenue of $26.9 million, up 16.8% compared to the second quarter of 2025
Adjusted EBITDA of $0.3 million compared to a loss of

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Tue, 11 Aug 2026 07:50:00 -0400

MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced its financial and operating results for the second quarter of 2026.

Second Quarter 2026 Financial Highlights

Total revenue of $41.6 million, up 9.1% compared to the second quarter of 2025
Greenbrook revenue of $26.9 million, up 16.8% compared to the second quarter of 2025
Adjusted EBITDA of $0.3 million compared to a loss of

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

Tue, 11 Aug 2026 07:50:00 -0400

MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced its financial and operating results for the second quarter of 2026.

Second Quarter 2026 Financial Highlights

Total revenue of $41.6 million, up 9.1% compared to the second quarter of 2025
Greenbrook revenue of $26.9 million, up 16.8% compared to the second quarter of 2025
Adjusted EBITDA of $0.3 million compared to a loss of